These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 24401639)

  • 1. Treatment as prevention among injecting drug users; extrapolating from the Amsterdam cohort study.
    de Vos AS; Prins M; Coutinho RA; van der Helm JJ; Kretzschmar ME
    AIDS; 2014 Mar; 28(6):911-8. PubMed ID: 24401639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?
    de Vos AS; van der Helm JJ; Matser A; Prins M; Kretzschmar ME
    Addiction; 2013 Jun; 108(6):1070-81. PubMed ID: 23347124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users.
    de Vos AS; van der Helm JJ; Prins M; Kretzschmar ME
    Epidemics; 2012 Jun; 4(2):57-67. PubMed ID: 22664064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment.
    Mientjes GH; van Ameijden EJ; van den Hoek AJ; Goudsmit J; Miedema F; Coutinho RA
    AIDS; 1993 Oct; 7(10):1363-70. PubMed ID: 8267910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study.
    Lindenburg CE; Krol A; Smit C; Buster MC; Coutinho RA; Prins M
    AIDS; 2006 Aug; 20(13):1771-5. PubMed ID: 16931942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection among intravenous drug users: epidemiology and risk reduction.
    Des Jarlais DC; Friedman SR
    AIDS; 1987 Jul; 1(2):67-76. PubMed ID: 3130084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing HIV infection among new injecting drug users in the China-Vietnam Cross Border Project.
    Des Jarlais DC; Kling R; Hammett TM; Ngu D; Liu W; Chen Y; Binh KT; Friedmann P
    AIDS; 2007 Dec; 21 Suppl 8():S109-14. PubMed ID: 18172378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the size of the HIV epidemic among injecting drug users in Amsterdam.
    van Haastrecht HJ; Bindels PJ; van den Hoek AA; Coutinho RA
    Eur J Epidemiol; 1997 Apr; 13(3):261-5. PubMed ID: 9258523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam.
    Matser A; Urbanus A; Geskus R; Kretzschmar M; Xiridou M; Buster M; Coutinho R; Prins M
    Addiction; 2012 Mar; 107(3):614-23. PubMed ID: 21919987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the spread of HIV in social networks of injecting drug users.
    Kretzschmar M; Wiessing LG
    AIDS; 1998 May; 12(7):801-11. PubMed ID: 9619813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficiency of targeted intervention in limiting the spread of HIV and Hepatitis C Virus among injecting drug users.
    De Vos AS; Kretzschmar ME
    J Theor Biol; 2013 Sep; 333():126-34. PubMed ID: 23733004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.
    Weber R; Huber M; Rickenbach M; Furrer H; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Ledergerber B;
    HIV Med; 2009 Aug; 10(7):407-16. PubMed ID: 19490174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.
    Spillane H; Nicholas S; Tang Z; Szumilin E; Balkan S; Pujades-Rodriguez M
    Trop Med Int Health; 2012 Oct; 17(10):1255-63. PubMed ID: 22863110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study.
    Rasmussen LD; Engsig FN; Christensen H; Gerstoft J; Kronborg G; Pedersen C; Obel N
    AIDS; 2011 Aug; 25(13):1637-46. PubMed ID: 21646903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
    Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
    Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection among injecting drug users in Asia: an evolving public health crisis.
    Wodak A; Crofts N; Fisher R
    AIDS Care; 1993; 5(3):313-20. PubMed ID: 8218466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A success story: HIV prevention for injection drug users in Rhode Island.
    Beckwith CG; Moreira CC; Aboshady HM; Zaller N; Rich JD; Flanigan TP
    Subst Abuse Treat Prev Policy; 2006 Dec; 1():34. PubMed ID: 17144920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.